1. Hossain I, Milne C. Can regenerative medicine help close the gap between the medicine pipeline and public health burden of cardiovascular and musculoskeletal diseases? Clin Ther. 2018;40(7):1066–75.
2. Global regenerative medicines market—analysis and forecast (2017–2025) (Focus on therapy, applications, market share analysis, 22 country analysis, and competitive landscape). Market Research, Business Wire. Available at: www.reportlinker.com/p05292525/Global-Regenerative-Medicines-Market-Analysis-and-Forecast-Focus-on-Therapy-Applications-Market-Share-Analysis-22-Country-Analysis-and-Competitive-Landscape.html. Accessed 12 Oct 2020.
3. Musculoskeletal Disorder (MSD) Signs and Symptoms. Mohawk College. Available at: www.mohawkcollege.ca/employees/occupational-health-tolerability/ergonomics/musculoskeletal-disorder-msd-signs-and-symptoms. Accessed 12 Oct 2020.
4. US Food and Drug Administration, Office of the Commissioner. 21st Century Cures Act. Available at: www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/21stCenturyCuresAct/default.htm. Accessed 12 Oct 2020.
5. US Food and Drug Administration, Center for Biologics Evaluation and Research. Cellular & gene therapy products—regenerative medicine advanced therapy designation. Available at: www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ucm537670.htm. Accessed 12 Oct 2020.